{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:14Z","timestamp":1791297914546,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.taap.2013.10.032","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T01:02:12Z","timestamp":1383786132000},"page":"124-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Hepatocyte-based in vitro model for assessment of drug-induced cholestasis"],"prefix":"10.1016","volume":"274","author":[{"given":"Sagnik","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysiane","family":"Richert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Augustijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-7351","authenticated-orcid":false,"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2013.10.032_bb0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2013.10.032_bb0010","doi-asserted-by":"crossref","first-page":"968","DOI":"10.3109\/00498254.2012.676693","article-title":"Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers","volume":"42","author":"Alexandre","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.taap.2013.10.032_bb0015","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-007-9289-1","article-title":"Bile acid transporters: structure, function, regulation and pathophysiological implications","volume":"24","author":"Alrefai","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2013.10.032_bb0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/dmd.104.001669","article-title":"Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes","volume":"33","author":"Annaert","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0025","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/dmd.109.028407","article-title":"An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes","volume":"38","author":"Ansede","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0030","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human heparg cells","volume":"57","author":"Anth\u00ebrieu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2013.10.032_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0306-9877(86)90137-4","article-title":"Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids","volume":"19","author":"Attili","year":"1986","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.taap.2013.10.032_bb0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hep.20729","article-title":"Intrahepatic cholestasis: summary of an American Association for the Study of Liver Diseases single-topic conference","volume":"42","author":"Balistreri","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2013.10.032_bb0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2002-30099","article-title":"Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions","volume":"22","author":"Bohan","year":"2002","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.taap.2013.10.032_bb0050","first-page":"65","article-title":"Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity","volume":"288","author":"Bort","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.10.032_bb0055","article-title":"Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: role of glycine conjugates","author":"Chatterjee","year":"2013","journal-title":"Toxicol. In vitro"},{"key":"10.1016\/j.taap.2013.10.032_bb0060","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hep.23984","article-title":"Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: studies in Oatp1b2-null mice","volume":"53","author":"Csanaky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2013.10.032_bb0065","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","article-title":"Bile acid transporters","volume":"50","author":"Dawson","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2013.10.032_bb0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0075","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1517\/17425255.2013.773973","article-title":"Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity","volume":"9","author":"De Bruyn","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2013.10.032_bb0080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/11202270-000000000-00000","article-title":"Bosentan: a review of its use in the management of mildly symptomatic pulmonary arterial hypertension","volume":"9","author":"Dhillon","year":"2009","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.taap.2013.10.032_bb0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","article-title":"Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)","volume":"453","author":"Elferink","year":"2007","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.taap.2013.10.032_bb0090","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Epstein","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2013.10.032_bb0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1067\/mcp.2001.114667","article-title":"The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions","volume":"69","author":"Fattinger","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2013.10.032_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-8981(96)06305-X","article-title":"Hepatic levels of bile acids in end-stage chronic cholestatic liver disease","volume":"251","author":"Fischer","year":"1996","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.taap.2013.10.032_bb0105","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/mol.113.086967","article-title":"HIV protease inhibitors interact with ABCC4\/MRP4: a basis for unanticipated enhanced cytotoxicity","volume":"84","author":"Fukuda","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2013.10.032_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0300-483X(01)00460-7","volume":"167","author":"Funk","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2013.10.032_bb0115","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.3748\/wjg.15.3134","article-title":"Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease","volume":"15","author":"Gnewuch","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2013.10.032_bb0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/dmd.32.6.639","article-title":"Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved","volume":"32","author":"He","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0125","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2133\/dmpk.18.16","article-title":"Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans","volume":"18","author":"Horikawa","year":"2003","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2013.10.032_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1183\/09031936.00138706","article-title":"Results of European post-marketing surveillance of bosentan in pulmonary hypertension","volume":"30","author":"Humbert","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.taap.2013.10.032_bb0135","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1124\/dmd.108.020370","article-title":"Bioactivation of flutamide metabolites by human liver microsomes","volume":"36","author":"Kang","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.taap.2011.03.004","article-title":"Glutathione depletion by valproic acid in sandwich-cultured rat hepatocytes: role of biotransformation and temporal relationship with onset of toxicity","volume":"252","author":"Kiang","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.10.032_bb0145","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00007890-198112000-00007","article-title":"Cyclosporin A hepatotoxicity in 66 renal allograft recipients","volume":"32","author":"Klintmalm","year":"1981","journal-title":"Transplantation"},{"key":"10.1016\/j.taap.2013.10.032_bb0150","first-page":"35","article-title":"Hepatic levels of cyclosporine and metabolites in patients after liver transplantation","volume":"9","author":"Lacerda","year":"1995","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.taap.2013.10.032_bb0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0950-3528(88)90010-3","article-title":"Drug-induced cholestasis","volume":"2","author":"Larrey","year":"1988","journal-title":"Baillieres Clin. Gastroenterol."},{"key":"10.1016\/j.taap.2013.10.032_bb0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2337\/diacare.25.5.815","article-title":"Evaluation of liver function in type 2 diabetic patients during clinical trials evidence that rosiglitazone does not cause hepatic dysfunction","volume":"25","author":"Lebovitz","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.taap.2013.10.032_bb0165","first-page":"920","article-title":"Tissue distribution of erythromycin in rats","volume":"3","author":"Lee","year":"1953","journal-title":"Antibiot. Chemother."},{"key":"10.1016\/j.taap.2013.10.032_bb0170","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","article-title":"Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1) by bosentan: a mechanism for species differences in hepatotoxicity","volume":"321","author":"Leslie","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2013.10.032_bb0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1089-3261(05)70079-9","article-title":"Drug- and chemical-induced cholestasis","volume":"3","author":"Lewis","year":"1999","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.taap.2013.10.032_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0300-483X(02)00143-9","article-title":"Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats","volume":"176","author":"Li","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2013.10.032_bb0185","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1067\/mcp.2000.104736","article-title":"Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation","volume":"67","author":"Manyike","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2013.10.032_bb0190","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/mp0700357","article-title":"Use of sandwich-cultured hepatocytes to evaluate impaired bile acid transport as a mechanism of drug-induced hepatotoxicity","volume":"4","author":"Marion","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.taap.2013.10.032_bb0195","first-page":"4931","article-title":"Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis","volume":"11","author":"Marra","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2013.10.032_bb0200","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.10.032_bb0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/15563659509028930","article-title":"Ticlopidine-induced prolonged cholestasis","volume":"33","author":"Naschitz","year":"1995","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.taap.2013.10.032_bb0210","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug-related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2013.10.032_bb0215","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/BF02774694","article-title":"Intrahepatic cholestasis and hyperbilirubinemia in ethynyl estradiol and chlorpromazine-treated rats","volume":"18","author":"Obata","year":"1983","journal-title":"Gastroenterol. Jpn."},{"key":"10.1016\/j.taap.2013.10.032_bb0220","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2013.10.032_bb0225","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1124\/dmd.113.052415","article-title":"Transcriptomic hepatotoxicity signature of chlorpromazine after short and long-term exposure in primary human sandwich cultures","volume":"41","author":"Parmentier","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0230","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2013.10.032_bb0235","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3748\/wjg.15.1677","article-title":"Bile-acid-induced cell injury and protection","volume":"15","author":"Perez","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2013.10.032_bb0240","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/cid\/cis620","article-title":"Complicated atazanavir-associated cholelithiasis: a report of 14 cases","volume":"55","author":"Rakotondravelo","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.taap.2013.10.032_bb0245","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1073\/pnas.0712328105","article-title":"The organic solute transporter \u03b1\u2013\u03b2, Ost\u03b1\u2013Ost\u03b2, is essential for intestinal bile acid transport and homeostasis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2013.10.032_bb0250","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1665-2681(19)32126-X","article-title":"Cholestasis: human disease and experimental animal models","volume":"2","author":"Rodriguez-Garay","year":"2003","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.taap.2013.10.032_bb0255","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0925-4439(02)00224-7","article-title":"Mitochondrially mediated synergistic cell killing by bile acids","volume":"1637","author":"Rolo","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.taap.2013.10.032_bb0260","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","article-title":"Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry","volume":"877","author":"Scherer","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.taap.2013.10.032_bb0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/toxsci\/kfm077","article-title":"Uniform procedure of 1H NMR analysis of rat urine and toxicometabonomics part II: comparison of NMR profiles for classification of hepatotoxicity","volume":"98","author":"Schoonen","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.10.032_bb0270","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0016-5085(97)70239-7","article-title":"Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei","volume":"112","author":"Setchell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2013.10.032_bb0275","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","article-title":"Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver","volume":"118","author":"Stieger","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2013.10.032_bb0280","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1086\/381444","article-title":"Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors","volume":"38","author":"Sulkowski","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.taap.2013.10.032_bb0285","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1124\/dmd.111.039545","article-title":"Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytes","volume":"39","author":"Tchaparian","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0290","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1056\/NEJM196211082671905","article-title":"Hepatic dysfunction and jaundice in patients receiving triacetyloleandomycin","volume":"267","author":"Ticktin","year":"1962","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2013.10.032_bb0295","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","article-title":"New molecular insights into the mechanisms of cholestasis","volume":"51","author":"Wagner","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2013.10.032_bb0300","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1124\/dmd.108.020842","article-title":"Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes","volume":"36","author":"Wolf","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2013.10.032_bb0310","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/FPC.0b013e32832bcf7b","article-title":"Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans","volume":"19","author":"Xiang","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.taap.2013.10.032_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2009.11.019","article-title":"High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma","volume":"878","author":"Xiang","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.taap.2013.10.032_bb0315","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/toxsci\/kfn109","article-title":"Cellular imaging predictions of clinical drug-induced liver injury","volume":"105","author":"Xu","year":"2008","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2013.10.032_bb0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.taap.2013.01.018","article-title":"Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats","volume":"268","author":"Yamazaki","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2013.10.032_bb0325","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/bjp.2008.267","article-title":"Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model","volume":"154","author":"Yao","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2013.10.032_bb0330","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1124\/mol.112.081752","article-title":"Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites","volume":"83","author":"Yoshikado","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2013.10.032_bb0335","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bcp.2010.11.002","article-title":"The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells","volume":"81","author":"Zahno","year":"2011","journal-title":"Biochem. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13004808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X13004808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T23:38:31Z","timestamp":1564616311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X13004808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0041008X13004808"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2013.10.032","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2013.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}